CYLINFY Trademark

Trademark Overview


On Thursday, February 20, 2025, a trademark application was filed for CYLINFY with the United States Patent and Trademark Office. The USPTO has given the CYLINFY trademark a serial number of 79421623. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, October 1, 2025. This trademark is owned by Gilead Sciences Ireland UC. The CYLINFY trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
cylinfy

General Information


Serial Number79421623
Word MarkCYLINFY
Filing DateThursday, February 20, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateWednesday, October 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 17, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIE

Trademark Events


Event DateEvent Description
Thursday, April 17, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 2, 2025ASSIGNED TO EXAMINER
Friday, May 2, 2025NON-FINAL ACTION WRITTEN
Saturday, May 3, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 5, 2025REFUSAL PROCESSED BY MPU
Wednesday, August 6, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 25, 2025APPLICATION FILING RECEIPT MAILED
Saturday, August 23, 2025REFUSAL PROCESSED BY IB
Monday, September 22, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 22, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 1, 2025APPROVED FOR PUB - PRINCIPAL REGISTER